Development and evaluation of age-appropriate film-coated tablets of levamisole for paediatric use (2 – 18 years)
Author:
Publisher
Informa Healthcare
Subject
Pharmaceutical Science
Link
http://www.tandfonline.com/doi/pdf/10.1517/17425247.2013.745849
Reference20 articles.
1. Levamisole, the story and the lessons
2. Treatment of nephrotic syndrome with levamisole
3. Levamisole for corticosteroid-dependent nephrotic syndrome in childhood
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. From Bench to Bedside: What Do We Know about Imidazothiazole Derivatives So Far?;Molecules;2023-06-28
2. Biowaiver Monograph for Immediate-Release Dosage Forms: Levamisole Hydrochloride;Journal of Pharmaceutical Sciences;2023-03
3. Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children;International Journal of Clinical Pharmacy;2022-10-08
4. From paediatric formulations development to access: Advances made and remaining challenges;British Journal of Clinical Pharmacology;2022-05-18
5. Individualized orodispersible pediatric dosage forms obtained by molding and semi-solid extrusion by 3D printing: A comparative study for hydrochlorothiazide;Journal of Drug Delivery Science and Technology;2021-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3